{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:55:22Z","timestamp":1777416922088,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08059-7","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:01:36Z","timestamp":1749531696000},"page":"857-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thioredoxin-interacting protein is associated with obesity-induced insulin resistance in PCOS patients: a large-scale case\u2013control study"],"prefix":"10.1007","volume":"312","author":[{"given":"Miao","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"9","key":"8059_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ (2022) Polycystic ovary syndrome. Lancet Diabetes Endocrinol 10(9):668\u2013680. https:\/\/doi.org\/10.1016\/s2213-8587(22)00163-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"8059_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5114\/aoms.2019.87112","volume":"17","author":"T Miazgowski","year":"2021","unstructured":"Miazgowski T, Martopullo I, Widecka J, Miazgowski B, Brodowska A (2021) National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016. Arch Med Sci 17(2):343\u2013351. https:\/\/doi.org\/10.5114\/aoms.2019.87112","journal-title":"Arch Med Sci"},{"issue":"1","key":"8059_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12958-023-01160-z","volume":"21","author":"L Rahmatnezhad","year":"2023","unstructured":"Rahmatnezhad L, Moghaddam-Banaem L, Behroozi-Lak T, Shiva A, Rasouli J (2023) Association of insulin resistance with polycystic ovary syndrome phenotypes and patients\u2019 characteristics: a cross-sectional study in Iran. Reprod Biol Endocrinol 21(1):113. https:\/\/doi.org\/10.1186\/s12958-023-01160-z","journal-title":"Reprod Biol Endocrinol"},{"key":"8059_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120869","author":"W Chen","year":"2021","unstructured":"Chen W, Pang Y (2021) Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. https:\/\/doi.org\/10.3390\/metabo11120869","journal-title":"Metabolites"},{"key":"8059_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13020302","author":"M Jabczyk","year":"2023","unstructured":"Jabczyk M, Nowak J, Jagielski P, Hudzik B, Kulik-Kupka K, W\u0142odarczyk A, Lar K, Zubelewicz-Szkodzi\u0144ska B (2023) Metabolic deregulations in patients with polycystic ovary syndrome. Metabolites. https:\/\/doi.org\/10.3390\/metabo13020302","journal-title":"Metabolites"},{"key":"8059_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","volume":"13","author":"F Guo","year":"2022","unstructured":"Guo F, Gong Z, Fernando T, Zhang L, Zhu X, Shi Y (2022) The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in chinese population. Front Endocrinol (Lausanne) 13:892125. https:\/\/doi.org\/10.3389\/fendo.2022.892125","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"8059_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16(1):9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"issue":"1","key":"8059_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/s0954422416000287","volume":"30","author":"YM Jeanes","year":"2017","unstructured":"Jeanes YM, Reeves S (2017) Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev 30(1):97\u2013105. https:\/\/doi.org\/10.1017\/s0954422416000287","journal-title":"Nutr Res Rev"},{"key":"8059_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP (2018) Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86:33\u201343. https:\/\/doi.org\/10.1016\/j.metabol.2017.09.016","journal-title":"Metabolism"},{"key":"8059_CR10","doi-asserted-by":"publisher","unstructured":"Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H, Kamenov Z (2022) Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome. Arch Endocrinol Metab 66(1):3\u201311. https:\/\/doi.org\/10.20945\/2359-3997000000442","DOI":"10.20945\/2359-3997000000442"},{"key":"8059_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010222","author":"P Kabakchieva","year":"2024","unstructured":"Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H, Kamenov Z (2024) Meteorin-like protein and zonulin in polycystic ovary syndrome: exploring associations with obesity, metabolic parameters, and inflammation. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12010222","journal-title":"Biomedicines"},{"issue":"11","key":"8059_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/archdischild-2014-306471","volume":"100","author":"N Hecht Baldauff","year":"2015","unstructured":"Hecht Baldauff N, Arslanian S (2015) Optimal management of polycystic ovary syndrome in adolescence. Arch Dis Child 100(11):1076\u20131083. https:\/\/doi.org\/10.1136\/archdischild-2014-306471","journal-title":"Arch Dis Child"},{"issue":"1","key":"8059_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS et al (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97(1):28-38.e25. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024","journal-title":"Fertil Steril"},{"key":"8059_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052754","author":"N Qayyum","year":"2021","unstructured":"Qayyum N, Haseeb M, Kim MS, Choi S (2021) Role of thioredoxin-interacting protein in diseases and its therapeutic outlook. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22052754","journal-title":"Int J Mol Sci"},{"issue":"6","key":"8059_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ars.2011.4137","volume":"16","author":"ON Spindel","year":"2012","unstructured":"Spindel ON, World C, Berk BC (2012) Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal 16(6):587\u2013596. https:\/\/doi.org\/10.1089\/ars.2011.4137","journal-title":"Antioxid Redox Signal"},{"key":"8059_CR16","doi-asserted-by":"publisher","unstructured":"(2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347. https:\/\/doi.org\/10.1093\/humrep\/deh098","DOI":"10.1093\/humrep\/deh098"},{"issue":"4","key":"8059_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/cen.12192","volume":"80","author":"J Wu","year":"2014","unstructured":"Wu J, Wu Y, Zhang X, Li S, Lu D, Li S, Yang G, Liu D (2014) Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance. Clin Endocrinol (Oxf) 80(4):538\u2013544. https:\/\/doi.org\/10.1111\/cen.12192","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1\u20133","key":"8059_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","volume":"122","author":"CG Baptiste","year":"2010","unstructured":"Baptiste CG, Battista MC, Trottier A, Baillargeon JP (2010) Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 122(1\u20133):42\u201352. https:\/\/doi.org\/10.1016\/j.jsbmb.2009.12.010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"8059_CR19","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1007\/s12035-018-0917-z","volume":"55","author":"S Nasoohi","year":"2018","unstructured":"Nasoohi S, Ismael S, Ishrat T (2018) Thioredoxin-interacting protein (TXNIP) in cerebrovascular and neurodegenerative diseases: regulation and implication. Mol Neurobiol 55(10):7900\u20137920. https:\/\/doi.org\/10.1007\/s12035-018-0917-z","journal-title":"Mol Neurobiol"},{"issue":"16","key":"8059_CR20","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1074\/jbc.M115.698365","volume":"291","author":"K Hong","year":"2016","unstructured":"Hong K, Xu G, Grayson TB, Shalev A (2016) Cytokines regulate \u03b2-Cell Thioredoxin-interacting protein (TXNIP) via distinct mechanisms and pathways. J Biol Chem 291(16):8428\u20138439. https:\/\/doi.org\/10.1074\/jbc.M115.698365","journal-title":"J Biol Chem"},{"issue":"8","key":"8059_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1210\/me.2014-1095","volume":"28","author":"A Shalev","year":"2014","unstructured":"Shalev A (2014) Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic \u03b2-cell. Mol Endocrinol 28(8):1211\u20131220. https:\/\/doi.org\/10.1210\/me.2014-1095","journal-title":"Mol Endocrinol"},{"issue":"9","key":"8059_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/1389450118666170130145514","volume":"18","author":"NM Alhawiti","year":"2017","unstructured":"Alhawiti NM, Al Mahri S, Aziz MA, Malik SS, Mohammad S (2017) TXNIP in metabolic regulation: physiological role and therapeutic outlook. Curr Drug Targets 18(9):1095\u20131103. https:\/\/doi.org\/10.2174\/1389450118666170130145514","journal-title":"Curr Drug Targets"},{"key":"8059_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111824","volume":"561","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang J, Wang Y, Chen Y, Wang Y, Kuang H, Feng X (2023) Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome. Mol Cell Endocrinol 561:111824. https:\/\/doi.org\/10.1016\/j.mce.2022.111824","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"8059_CR24","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4239\/wjd.v12.i12.1979","volume":"12","author":"IN Mohamed","year":"2021","unstructured":"Mohamed IN, Li L, Ismael S, Ishrat T, El-Remessy AB (2021) Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response. World J Diabetes 12(12):1979\u20131999. https:\/\/doi.org\/10.4239\/wjd.v12.i12.1979","journal-title":"World J Diabetes"},{"issue":"9","key":"8059_CR25","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33(9):1602\u20131618. https:\/\/doi.org\/10.1093\/humrep\/dey256","journal-title":"Hum Reprod"},{"key":"8059_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101379","volume":"47","author":"Z Na","year":"2022","unstructured":"Na Z, Jiang H, Meng Y, Song J, Feng D, Fang Y, Shi B, Li D (2022) Association of galactose and insulin resistance in polycystic ovary syndrome: a case-control study. EClinicalMedicine 47:101379. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101379","journal-title":"EClinicalMedicine"},{"key":"8059_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.archger.2018.01.009","volume":"76","author":"J Li","year":"2018","unstructured":"Li J, Chen J, Qin Q, Zhao D, Dong B, Ren Q, Yu D, Bi P, Sun Y (2018) Chronic pain and its association with obesity among older adults in China. Arch Gerontol Geriatr 76:12\u201318. https:\/\/doi.org\/10.1016\/j.archger.2018.01.009","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"8059_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-0042-113463","volume":"49","author":"GA Abruzzese","year":"2017","unstructured":"Abruzzese GA, Cerrrone GE, Gamez JM, Graffigna MN, Belli S, Lioy G, Mormandi E, Otero P, Levalle OA, Motta AB (2017) Lipid accumulation product (LAP) and Visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 49(1):23\u201329. https:\/\/doi.org\/10.1055\/s-0042-113463","journal-title":"Horm Metab Res"},{"issue":"12","key":"8059_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s40618-015-0372-x","volume":"38","author":"MC Amato","year":"2015","unstructured":"Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C (2015) Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest 38(12):1319\u20131326. https:\/\/doi.org\/10.1007\/s40618-015-0372-x","journal-title":"J Endocrinol Invest"},{"key":"8059_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"issue":"3","key":"8059_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5114\/aoms.2019.82672","volume":"15","author":"KC Lewandowski","year":"2019","unstructured":"Lewandowski KC, Skowro\u0144ska-J\u00f3\u017awiak E, \u0141ukasiak K, Ga\u0142uszko K, Dukowicz A, Cedro M, Lewi\u0144ski A (2019) How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models. Arch Med Sci 15(3):613\u2013618. https:\/\/doi.org\/10.5114\/aoms.2019.82672","journal-title":"Arch Med Sci"},{"key":"8059_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072374","author":"N Rabbani","year":"2021","unstructured":"Rabbani N, Xue M, Weickert MO, Thornalley PJ (2021) Reversal of insulin resistance in overweight and obese subjects by trans-resveratrol and hesperetin combination-link to dysglycemia, blood pressure, dyslipidemia, and low-grade inflammation. Nutrients. https:\/\/doi.org\/10.3390\/nu13072374","journal-title":"Nutrients"},{"issue":"3","key":"8059_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mito.2012.06.004","volume":"13","author":"J Zhou","year":"2013","unstructured":"Zhou J, Chng WJ (2013) Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion 13(3):163\u2013169. https:\/\/doi.org\/10.1016\/j.mito.2012.06.004","journal-title":"Mitochondrion"},{"issue":"10","key":"8059_CR34","doi-asserted-by":"publisher","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","volume":"97","author":"S Kaur","year":"2012","unstructured":"Kaur S, Archer KJ, Devi MG, Kriplani A, Strauss JF 3rd, Singh R (2012) Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. J Clin Endocrinol Metab 97(10):E2016-2021. https:\/\/doi.org\/10.1210\/jc.2011-3441","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"8059_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/jad-180814","volume":"68","author":"L Li","year":"2019","unstructured":"Li L, Ismael S, Nasoohi S, Sakata K, Liao FF, McDonald MP, Ishrat T (2019) Thioredoxin-interacting protein (TXNIP) associated NLRP3 inflammasome activation in human Alzheimer\u2019s disease brain. J Alzheimers Dis 68(1):255\u2013265. https:\/\/doi.org\/10.3233\/jad-180814","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8059_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cmet.2012.07.005","volume":"16","author":"CM Oslowski","year":"2012","unstructured":"Oslowski CM, Hara T, O\u2019Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu LJ, Hayashi E, Hui ST et al (2012) Thioredoxin-interacting protein mediates ER stress-induced \u03b2 cell death through initiation of the inflammasome. Cell Metab 16(2):265\u2013273. https:\/\/doi.org\/10.1016\/j.cmet.2012.07.005","journal-title":"Cell Metab"},{"issue":"6","key":"8059_CR37","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/db09-1212","volume":"59","author":"WA Chutkow","year":"2010","unstructured":"Chutkow WA, Birkenfeld AL, Brown JD, Lee HY, Frederick DW, Yoshioka J, Patwari P, Kursawe R, Cushman SW, Plutzky J et al (2010) Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 59(6):1424\u20131434. https:\/\/doi.org\/10.2337\/db09-1212","journal-title":"Diabetes"},{"issue":"3","key":"8059_CR38","first-page":"4363","volume":"8","author":"YC Zhao","year":"2015","unstructured":"Zhao YC, Zhu J, Song GY, Li XS (2015) Relationship between thioredoxin-interacting protein (TXNIP) and islet \u03b2-cell dysfunction in patients with impaired glucose tolerance and hypertriglyceridemia. Int J Clin Exp Med 8(3):4363\u20134368","journal-title":"Int J Clin Exp Med"},{"key":"8059_CR39","doi-asserted-by":"publisher","unstructured":"Dobosz AM, Dziewulska A, Dobrzy\u0144 A (2018) Spotlight on epigenetics as a missing link between obesity and type 2 diabetes. Postepy Biochem 64(2):157\u2013165. https:\/\/doi.org\/10.18388\/pb.2018_126","DOI":"10.18388\/pb.2018_126"},{"issue":"2","key":"8059_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/db10-0266","volume":"60","author":"TB Koenen","year":"2011","unstructured":"Koenen TB, Stienstra R, van Tits LJ, de Graaf J, Stalenhoef AF, Joosten LA, Tack CJ, Netea MG (2011) Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60(2):517\u2013524. https:\/\/doi.org\/10.2337\/db10-0266","journal-title":"Diabetes"},{"key":"8059_CR41","doi-asserted-by":"publisher","DOI":"10.1530\/ec-21-0641","author":"Z Lei","year":"2022","unstructured":"Lei Z, Chen Y, Wang J, Zhang Y, Shi W, Wang X, Xing D, Li D, Jiao X (2022) Txnip deficiency promotes \u03b2-cell proliferation in the HFD-induced obesity mouse model. Endocr Connect. https:\/\/doi.org\/10.1530\/ec-21-0641","journal-title":"Endocr Connect"},{"issue":"7","key":"8059_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/1753-0407.13021","volume":"12","author":"D Zhang","year":"2020","unstructured":"Zhang D, Cheng C, Cao M, Wang T, Chen X, Zhao Y, Wang B, Ren Y, Liu D, Liu L et al (2020) TXNIP hypomethylation and its interaction with obesity and hypertriglyceridemia increase type 2 diabetes mellitus risk: a nested case-control study. J Diabetes 12(7):512\u2013520. https:\/\/doi.org\/10.1111\/1753-0407.13021","journal-title":"J Diabetes"},{"issue":"1","key":"8059_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, Meczekalski B (2017) New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest 40(1):1\u20138. https:\/\/doi.org\/10.1007\/s40618-016-0523-8","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"8059_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1073\/pnas.1715930115","volume":"115","author":"K Nagaraj","year":"2018","unstructured":"Nagaraj K, Lapkina-Gendler L, Sarfstein R, Gurwitz D, Pasmanik-Chor M, Laron Z, Yakar S, Werner H (2018) Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action. Proc Natl Acad Sci U S A 115(5):1045\u20131050. https:\/\/doi.org\/10.1073\/pnas.1715930115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8059_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H (2022) Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther 7(1):216. https:\/\/doi.org\/10.1038\/s41392-022-01073-0","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"8059_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13098-024-01361-5","volume":"16","author":"Y Hua","year":"2024","unstructured":"Hua Y, Yin Z, Li M, Sun H, Shi B (2024) Correlation between circulating advanced glycation end products and thioredoxin-interacting protein levels and renal fat content in type 2 diabetes mellitus patients. Diabetol Metab Syndr 16(1):144. https:\/\/doi.org\/10.1186\/s13098-024-01361-5","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"8059_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55(1):31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013","journal-title":"Immunity"},{"key":"8059_CR48","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S (2019) Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health 13:1179558119874042. https:\/\/doi.org\/10.1177\/1179558119874042","journal-title":"Clin Med Insights Reprod Health"},{"issue":"4","key":"8059_CR49","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1074\/jbc.M708169200","volume":"283","author":"WA Chutkow","year":"2008","unstructured":"Chutkow WA, Patwari P, Yoshioka J, Lee RT (2008) Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. J Biol Chem 283(4):2397\u20132406. https:\/\/doi.org\/10.1074\/jbc.M708169200","journal-title":"J Biol Chem"},{"key":"8059_CR50","doi-asserted-by":"publisher","first-page":"1117761","DOI":"10.3389\/fendo.2023.1117761","volume":"14","author":"AE Butler","year":"2023","unstructured":"Butler AE, Moin ASM, Reiner \u017d, Sathyapalan T, Jamialahmadi T, Sahebkar A, Atkin SL (2023) High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome. Front Endocrinol (Lausanne) 14:1117761. https:\/\/doi.org\/10.3389\/fendo.2023.1117761","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8059_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF (2015) Role of homocysteine in the development of cardiovascular disease. Nutr J 14:6. https:\/\/doi.org\/10.1186\/1475-2891-14-6","journal-title":"Nutr J"},{"issue":"4","key":"8059_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1590\/2176-9451.19.4.027-029.ebo","volume":"19","author":"J Faber","year":"2014","unstructured":"Faber J, Fonseca LM (2014) How sample size influences research outcomes. Dental Press J Orthod 19(4):27\u201329. https:\/\/doi.org\/10.1590\/2176-9451.19.4.027-029.ebo","journal-title":"Dental Press J Orthod"},{"issue":"4","key":"8059_CR53","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/dom.14309","volume":"23","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Jablonski K, Delahanty LM, Maruthur NM, Leong A, Franks PW, Knowler WC, Florez JC, Dabelea D (2021) Interaction of diabetes genetic risk and successful lifestyle modification in the Diabetes Prevention Programme. Diabetes Obes Metab 23(4):1030\u20131040. https:\/\/doi.org\/10.1111\/dom.14309","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"8059_CR54","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","volume":"35","author":"CS Tam","year":"2012","unstructured":"Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35(7):1605\u20131610. https:\/\/doi.org\/10.2337\/dc11-2339","journal-title":"Diabetes Care"},{"issue":"8","key":"8059_CR55","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cellsig.2012.04.017","volume":"24","author":"TF Chai","year":"2012","unstructured":"Chai TF, Hong SY, He H, Zheng L, Hagen T, Luo Y, Yu FX (2012) A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. Cell Signal 24(8):1700\u20131705. https:\/\/doi.org\/10.1016\/j.cellsig.2012.04.017","journal-title":"Cell Signal"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08059-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:52:57Z","timestamp":1755935577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["8059"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08059-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6167416\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Hangzhou Women\u2019s Hospital (approval number: 2018\u201304-03), in compliance with the Declaration of Helsinki. Before participation, all participants were fully informed about the study\u2019s purpose, procedures, potential risks, and benefits. All sampling and laboratory procedures were conducted following the ethical guidelines of the hospital\u2019s Ethics Committee, ensuring participant privacy and safety. Identifiers were removed from data to maintain confidentiality, and all data were stored securely.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}